Survival association of XRCC1 for patients with head and neck squamous cell carcinoma: A systematic review and meta-analysis

ConclusionThis meta-analysis demonstrated that XRCC1 Arg399Gln and XRCC1 high protein expression increase the risk of poor survival for HNSCC patients. XRCC1 is a potential therapeutic target for HNSCC.
Source: Frontiers in Genetics - Category: Genetics & Stem Cells Source Type: research